Literature DB >> 11036104

Oncologist's role critical to clinical trial enrollment.

R Finn.   

Abstract

Mesh：

Year:  2000        PMID： 11036104     DOI： 10.1093/jnci/92.20.1632

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

1.  Challenges to National Cancer Institute-Supported Cooperative Group Clinical Trial Participation: An ASCO Survey of Cooperative Group Sites.

Authors:  Allison R Baer; Chelsey A Kelly; Suanna S Bruinooge; Carolyn D Runowicz; Douglas W Blayney
Journal:  J Oncol Pract       Date:  2010-04-15       Impact factor: 3.840

2.  Enhancing oncologist participation in research.

Authors: 
Journal:  J Oncol Pract       Date:  2009-11       Impact factor: 3.840

3.  Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions.

Authors:  Mihai Gheorghiade; Muthiah Vaduganathan; Stephen J Greene; Robert J Mentz; Kirkwood F Adams; Stefan D Anker; Malcolm Arnold; Fabio Baschiera; John G F Cleland; Gadi Cotter; Gregg C Fonarow; Christopher Giordano; Marco Metra; Frank Misselwitz; Eva Mühlhofer; Savina Nodari; W Frank Peacock; Burkert M Pieske; Hani N Sabbah; Naoki Sato; Monica R Shah; Norman L Stockbridge; John R Teerlink; Dirk J van Veldhuisen; Andrew Zalewski; Faiez Zannad; Javed Butler
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

4.  Follicular lymphoma in the United States: first report of the national LymphoCare study.

Authors:  Jonathan W Friedberg; Michael D Taylor; James R Cerhan; Christopher R Flowers; Hildy Dillon; Charles M Farber; Eric S Rogers; John D Hainsworth; Elaine K Wong; Julie M Vose; Andrew D Zelenetz; Brian K Link
Journal:  J Clin Oncol       Date:  2009-02-09       Impact factor: 44.544

5.  The relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial.

Authors:  S M Miller; S V Hudson; B L Egleston; S Manne; J S Buzaglo; K Devarajan; L Fleisher; J Millard; N Solarino; J Trinastic; N J Meropol
Journal:  Psychooncology       Date:  2012-02-14       Impact factor: 3.894
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.